VIH y COVID-19: Una revisión narrativa rápida.
Contenido principal del artículo
Resumen
Introducción: El impacto del SARS-CoV-2 en la pandemia del VIH, era desconocido en enero del 2020, pero transcurridos casi seis meses de la aparición del COVID-19, ya contamos con variadas publicaciones académicas de esta sindemia.
El presente artículo es una revisión narrativa rápida de la literatura científica actual sobre VIH y COVID-19.
Metodología: Se revisaron publicaciones en buscadores académicos a mediados de mayo del 2020 sobre VIH y COVID-19.
Se encontraron editoriales y cartas al editor, correspondencia, viewpoint, artículos originales [algunos pre-print], notas de campo y comentarios. Todos con valiosa información clínica sobre la relación entre ambas epidemias.
Desarrollo: Se clasificaron las publicaciones temáticamente en: respuesta clínica de personas VIH positivas afectadas por el COVID-19, farmacología, mantención y adaptación de los servicios de salud sexual, lecciones del VIH para la respuesta al COVID-19, poblaciones clave, efectos psicosociales, estigma y discriminación.
Conclusiones: No hay evidencia de que personas VIH positivas, en TARV y por tanto, sin compromiso inmune, tengan mayor riesgo de COVID-19; tampoco en personas en etapa SIDA.
Sí hay evidencia de mayor riesgo con edad avanzada y comorbilidades. No hay evidencia que sostenga que el TARV es efectivo para el SARS-CoV-2.
Los servicios de salud sexual pueden y deben adaptarse a la contingencia. El VIH entrega importantes lecciones para la respuesta al COVID-19. Las poblaciones clave, requieren especial protección.
Los efectos psicosociales y el estigma y la discriminación del COVID-19 y el VIH, generan impactos en la respuesta de la epidemia.
Descargas
Detalles del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Citas
Kenmoe S, Bigna J, Fatawou
Modiyingi A, Ndangang M, Ngoupo P,
Simo F et al. Case fatality rate and viral
aetiologies of acute respiratory tract
infections in HIV positive and negative
people in Africa: The VARIAFRICAHIV systematic review and metaanalysis. Journal of Clinical Virology.
; 117: 96-102.
https://doi.org/10.1016/j.jcv.2019.06.
Villamil-Gómez W, Sánchez Á, Gelis
L, Silvera L, Barbosa J, Otero-Nader O
et al. Fatal human coronavirus 229E
(HCoV-229E) and RSV–Related
pneumonia in an AIDS patient from
Colombia. Travel Medicine and
Infectious Disease. 2020;
https://doi.org/10.1016/j.tmaid.2020.1
Center for Disease Control [CDC].
What to know about HIV and COVID19. 2020 [cited 14 June 2020].
Available from:
https://www.cdc.gov/coronavirus/201
-ncov/need-extraprecautions/hiv.html
Yang R, Gui X, Gao S, et al. The
reflection on an AIDS patient with
asymptomatic COVID-19. Research
Square [preprint]. 2020.
DOI: 10.21203/rs.3.rs-18738/v1
Favas, C. Guidance for the prevention
of COVID-19 infections among high
risk individuals in camps and camp
like settings. London School of
Hygiene & Tropical Medicine. 31
March 2020 [cited 11 June 2020].
Available from:
Moni M, Liò P. Network-based
analysis of comorbidities risk during
an infection: SARS and HIV case studies. BMC Bioinformatics.
;15(1):1-23.
https://doi.org/10.1186/1471-2105-
-333
Gervasoni C, Meraviglia P, Riva A,
Giacomelli A, Oreni L, Minisci D et al.
Clinical features and outcomes of HIV
patients with coronavirus disease
Clinical Infectious Diseases
[preprint]. 2020 [cited 7 June 2020].
Available from:
https://pubmed.ncbi.nlm.nih.gov/3240
/
Härter, G., Spinner, C.D., Roider, J. et
al. COVID-19 in people living with
human immunodeficiency virus: a case
series of 33 patients. Infection (2020).
https://doi.org/10.1007/s15010-020-
-z
Wu Q, Chen T, Zhang H. Recovery
from COVID-19 in two patients with
coexisted HIV infection. J Med Virol
[preprint]. 2020 [cited 7 June 2020].
Recuperado de:
https://doi.org/10.1002/jmv.26006
Blanco J, Ambrosioni J, Garcia F,
Martínez E, Soriano A, Mallolas J et
al. COVID-19 in patients with HIV:
clinical case series. The Lancet HIV.
;7(5): e314-e316.
https://doi.org/10.1016/S2352-
(20)30111-9
Altuntas Aydin O, Kumbasar
Karaosmanoglu H, Kart Yasar K.
HIV/SARS‐CoV‐2 coinfected patients
in Istanbul, Turkey. Journal of Medical
Virology [Internet]. 2020 [cited 8 June
;1-3.
https://doi.org/10.1002/jmv.25955
Laurence J. Why Aren't People Living
with HIV at Higher Risk for
Developing Severe Coronavirus Disease 2019 (COVID-19)?. AIDS
Patient Care and STDs.
;34(6):247-248.
https://doi.org/10.1089/apc.2020.2900
com
Zhao J, Liao X, Wang H, et al. Early
virus clearance and delayed antibody
response in a case of COVID-19 with
a history of co-infection with HIV-1
and HCV [published online ahead of
print, 2020 Apr 9]. Clin Infect Dis.
; ciaa408.
https://doi.org/10.1093/cid/ciaa408
Guo, Wei and Ming, Fangzhao and
Dong, Yu and Zhang, Qian and Zhang,
Xiaoxia and Mo, Pingzheng and Feng,
Yong and Liang, Ke. A Survey for
COVID-19 Among HIV/AIDS
Patients in Two Districts of Wuhan,
China. The Lancet [preprint].
Available at
http://dx.doi.org/10.2139/ssrn.355002
Cao B, Wang Y, Wen D, Liu W, Wang
J, Fan G et al. A Trial of Lopinavir–
Ritonavir in Adults Hospitalized with
Severe Covid-19. New England
Journal of Medicine.
;382(19):1787-1799. DOI:
1056/NEJMoa2001282
Copertino Jr. D, Lima B, Duarte R,
Wilkin T, Gulick R, de Mulder
Rougvie M et al. Antiretroviral Drug
Activity and Potential for PreExposure Prophylaxis Against
COVID-19 and HIV Infection.
ChemRxiv [preprint]. 2020 [cited 8
June 2020]. Available from:
https://chemrxiv.org/articles/Antiretro
viral_Drug_Activity_and_Potential_f
or_PreExposure_Prophylaxis_Against_COVID19_and_HIV_Infection/12250199/
?file=22537484
Mitjà O, Clotet B. Use of antiviral
drugs to reduce COVID-19
transmission. The Lancet Global
Health. 2020;8(5): e639-e640.
https://doi.org/10.1016/S2214-
X(20)30114-5
Lack of evidence to support use of
darunavir-based treatments for SARSCoV-2 [Internet]. Janssen UK. 2020
[cited 15 June 2020]. Available from:
https://www.janssen.com/uk/sars-cov2-treatment
Nyoni, T., Okumu, M. COVID-19-
Compliant Strategies for Supporting
Treatment Adherence Among People
Living with HIV in Sub-Saharan
Africa. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-0
Lodge W, Kuchukhidze S. COVID-19,
HIV, and Migrant Workers: The
Double Burden of the Two Viruses.
AIDS Patient Care and STDs.
;34(6):249-250. DOI:
https://doi.org/10.1089/apc.2020.0092
Shiau, S., Krause, K.D., Valera, P. et
al. The Burden of COVID-19 in
People Living with HIV: A Syndemic
Perspective. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-9
Jiang H, Zhou Y, Tang W. Maintaining
HIV care during the COVID-19
pandemic. The Lancet HIV. 2020;7(5):
e308-e309.
https://doi.org/10.1016/S2352-
(20)30105-3
Stanford, K.A., Friedman, E.E.,
Schmitt, J. et al. Routine Screening for
HIV in an Urban Emergency Department During the COVID-19
Pandemic. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-x
Nosyk B, Armstrong W, del Rio C.
Contact tracing for COVID-19: An
opportunity to reduce health disparities
and End the HIV/AIDS Epidemic in
the US. Clinical Infectious Diseases
[preprint]. 2020 [cited 7 June 2020].
Available from:
https://www.ncbi.nlm.nih.gov/pmc/art
icles/PMC7197593/
Adepoju P. Tuberculosis and HIV
responses threatened by COVID-19.
The Lancet HIV. 2020;7(5): e319-
e320. https://doi.org/10.1016/S2352-
(20)30109-0
Beima-Sofie, K., Ortblad, K.F.,
Swanson, F. et al. “Keep It Going if
You Can”: HIV Service Provision for
Priority Populations During the
COVID-19 Pandemic in Seattle,
WA. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
McLinden, T., Stover, S. & Hogg, R.S.
HIV and Food Insecurity: A Syndemic
Amid the COVID-19 Pandemic. AIDS
Behav (2020).
https://doi.org/10.1007/s10461-020-
-3
Kay, E.S., Musgrove, K. From HIV to
Coronavirus: AIDS Service
Organizations Adaptative Responses
to COVID-19, Birmingham,
Alabama. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-1
Kowalska J, Skrzat-Klapaczyńska A,
Bursa D, Balayan T, Begovac J,
Chkhartishvili N et al. HIV care in times of the COVID-19 crisis —
Where are we now in Central and
Eastern Europe? International Journal
of Infectious Diseases. 2020; 96: 311-
https://doi.org/10.1016/j.ijid.2020.05.
ONUSIDA. Enfermedad por
Coronavirus (COVID-19) and HIV:
Asuntos y Acciones Claves -
OPS/OMS | Organización
Panamericana de la Salud [Internet].
Paho.org. 2020 [cited 11 June 2020].
Available from:
https://www.paho.org/es/documentos/
enfermedad-por-coronavirus-covid19-and-hiv-asuntos-acciones-claves
Rights in the time of COVID-19 —
Lessons from HIV for an effective,
community-led response [Internet].
Unaids.org. 2020 [cited 15 June 2020].
Available from:
https://www.unaids.org/en/resources/
documents/2020/human-rights-andcovid-19
Wilkinson L, Grimsrud A. The time is
now: expedited HIV differentiated
service delivery during the COVID‐19
pandemic. Journal of the International
AIDS Society. 2020;23(5).
https://doi.org/10.1002/jia2.25503
Eaton L, Kalichman S. Social and
behavioral health responses to
COVID-19: lessons learned from four
decades of an HIV pandemic. Journal
of Behavioral Medicine.
;43(3):341-345.
https://doi.org/10.1007/s10865-020-
-y
Valdiserri, R.O., Holtgrave, D.R.
Responding to Pandemics: What
We’ve Learned from
HIV/AIDS. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-5
Hargreaves J, Davey C, Hargreaves J,
Davey C, Auerbach J, Blanchard J et
al. Three lessons for the COVID-19
response from pandemic HIV. The
Lancet HIV. 2020;7(5): e309-e311.
https://doi.org/10.1016/S2352-
(20)30110-7
Edelman, E.J., Aoun-Barakat, L.,
Villanueva, M. et al. Confronting
Another Pandemic: Lessons from HIV
can Inform Our COVID-19
Response. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-z
Harkness, A., Behar-Zusman, V. &
Safren, S.A. Understanding the Impact
of COVID-19 on Latino Sexual
Minority Men in a US HIV Hot
Spot. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-w
Algarin A, Varas-Rodríguez E,
Valdivia C, Fennie K, Larkey L, Hu N
et al. Symptoms, Stress, and HIVRelated Care Among Older People
Living with HIV During the COVID19 Pandemic, Miami, Florida. AIDS
and Behavior. 2020;1-3.
https://doi.org/10.1007/s10461-020-
-3
Carrico, A.W., Horvath, K.J., Grov,
C. et al. Double Jeopardy:
Methamphetamine Use and HIV as
Risk Factors for COVID-19. AIDS
Behav (2020).
https://doi.org/10.1007/s10461-020-
-w
Joseph Davey, D., Bekker, L., Coates,
T.J. et al. Contracting HIV or Contracting SAR-CoV-2 (COVID19) in Pregnancy? Balancing the Risks
and Benefits. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-x
Joska, J.A., Andersen, L., Rabie, S. et
al. COVID-19: Increased Risk to the
Mental Health and Safety of Women
Living with HIV in South
Africa. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-z
Hightow-Weidman, L., Muessig, K.,
Claude, K. et al. Maximizing Digital
Interventions for Youth in the Midst of
Covid-19: Lessons from the
Adolescent Trials Network for HIV
Interventions. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-w
Rogers, B.G., Coats, C.S., Adams,
E. et al. Development of Telemedicine
Infrastructure at an LGBTQ+ Clinic to
Support HIV Prevention and Care in
Response to COVID-19, Providence,
RI. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-1
Sanchez, T.H., Zlotorzynska, M., Rai,
M. et al. Characterizing the Impact of
COVID-19 on Men Who Have Sex
with Men Across the United States in
April, 2020. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-2
Strategic Considerations for
Mitigating the Impact of COVID-19
on Key- Population-Focused HIV
Programs [Internet]. Unaids.org. 2020
[cited 15 June 2020]. Available from:
https://www.unaids.org/sites/default/fi
les/media_asset/kp-strategicconsiderations-covid19_en.pdf
Operario, D., King, E.J. & Gamarel,
K.E. Prioritizing Community Partners
and Community HIV Workers in the
COVID-19 Pandemic. AIDS
Behav (2020).
https://doi.org/10.1007/s10461-020-
-0
Pinto, R.M., Park, S. COVID-19
Pandemic Disrupts HIV Continuum of
Care and Prevention: Implications for
Research and Practice Concerning
Community-Based Organizations and
Frontline Providers. AIDS
Behav (2020).
https://doi.org/10.1007/s10461-020-
-3
Shoptaw, S., Goodman-Meza, D. &
Landovitz, R.J. Collective Call to
Action for HIV/AIDS CommunityBased Collaborative Science in the Era
of COVID-19. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-y
Ballester-Arnal, R., Gil-Llario, M.D.
The Virus that Changed Spain: Impact
of COVID-19 on People with
HIV. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-3
Marziali, M.E., Card, K.G.,
McLinden, T. et al. Physical
Distancing in COVID-19 May
Exacerbate Experiences of Social
Isolation among People Living with
HIV. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-8
Logie C. Lessons learned from HIV
can inform our approach to COVID‐19
stigma. Journal of the International AIDS Society. 2020;23(5):1-3.
https://doi.org/10.1002/jia2.25504
Krier, S., Bozich, C., Pompa, R. et
al. Assessing HIV-Related Stigma in
Healthcare Settings in the Era of the
COVID-19 Pandemic, Pittsburgh,
Pennsylvania. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-4
Logie, C.H., Turan, J.M. How Do We
Balance Tensions Between COVID-19
Public Health Responses and Stigma
Mitigation? Learning from HIV
Research. AIDS Behav (2020).
https://doi.org/10.1007/s10461-020-
-8
Villanueva S. Infecciones y estigmas:
lecciones de la pandemia del VIH para
el mañana de la COVID-19 [Internet].
The Conversation. 2020 [cited 10 June
. Available from:
https://theconversation.com/infeccion
es-y-estigmas-lecciones-de-lapandemia-del-vih-para-el-manana-dela-covid-19-135522
Relf MV. What's Old is New!
Similarities Between SARS-CoV-2
and HIV. J Assoc Nurses AIDS Care.
;31(3):263‐265.